‌

US Patent 10793561 1,8-naphthyridinone compounds and uses thereof

Patent 10793561 was granted and assigned to Nuvation Bio on October, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

October 6, 2020

0

Patent Application Number

160393010

Date Filed

July 18, 2018

0

Patent Citations

US Patent 10336697 Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors

0

US Patent 10336722 Tetrahydroquinoline compositions as BET bromodomain inhibitors

0

US Patent 10363257 Bicyclic bromodomain inhibitors

US Patent 10370356 Pyridinone dicarboxamide for use as bromodomain inhibitors

US Patent 10370374 Heterocyclic compounds and uses thereof

US Patent 10377769 Benzopiperazine compositions as BET bromodomain inhibitors

US Patent 10391175 BET bromodomain inhibitors and therapeutic methods using the same

0

US Patent 10472347 Aminopyrazine compounds with A2A antagonist properties

...

Patent Citations Received

US Patent 11306071 Heterocyclic compounds as adenosine antagonists

US Patent 11254670 1,8-naphthyridinone compounds and uses thereof

Patent Primary Examiner

D Margaret M Seaman

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10793561 1,8-naphthyridinone compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.